Skin manifestations in CD4+, CD56+ malignancies

European Journal of Dermatology

Volumn 13, Issue 2, 2003, Pages 161-165

  Penven, Katell ^a   Macro, Margaret ^a   Salaün, Véronique ^a   Comoz, François ^a   Reman, Oumedaly ^a   Leroy, Dominique ^a   Troussard, Xavier ^a   Petrella, Tony ^b   Dompmartin, Anne ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b CHU ^*  (France)

Author keywords

CD4; CD56; Granulocytic sarcoma; Hematodermic neoplasm; Leukemia cutis; Plasmacytoid dendritic cells

Indexed keywords

ALPHA2A INTERFERON; CD123 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; METHOTREXATE; METHYLPREDNISOLONE ACETATE; MITOXANTRONE; PREDNISOLONE; VINCRISTINE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER CYTODIAGNOSIS; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; CELL PROLIFERATION; CELL VACUOLE; CLINICAL FEATURE; DENDRITIC CELL; DISEASE MARKER; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHATIC LEUKEMIA; MALE; NATURAL KILLER CELL; SKIN CANCER; SKIN MANIFESTATION;

AGED; AGED, 80 AND OVER; ANTIGENS, CD56; CD4-POSITIVE T-LYMPHOCYTES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; INTERLEUKIN-3 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-3; SKIN NEOPLASMS;

EID: 0037360881     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Petrella T, Dalac S, Maynadié M, Mugneret F et al. CD4 +, CD56 +, cutaneous neoplasms: a distinct haematological entity ? Am J Surg Pathol 1999; 23: 137-46.
2. Robertson MJ, Ritz J. Biology and clinical relevance of human natural killer cells. Blood 1990; 76: 2421-38.
3. Ikushima S, Yoshihara T, Matsumura T, Misawa SI et al. Expression of CD56/NCAM on hematopoietic malignant cells. A useful marker for acute monocytic and megacaryocytic leukemias. Int J Hematol 1991; 54: 395-403.
4. Seymour JF, Pierce SA, Kantarjian HM, Keating MJ et al. Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56). Leukemia 1994; 8: 823-6.
5. Bene MC, Castoldi G, Knapp W, Ludwig WD et al. Proposals for the immunological classification of the acute leukemias. European Group for the Immunological Characterisation of Leukemias (EGIL). Leukemia 1995; 9: 1783-6.
6. Ratnam KV, Khor CJL, Su WPD. Leukemia cutis. Dermatol Clin 1994; 12: 419-43.
7. Sepp N, Radaszkiewicz T, Meijer CJLM, Smolle J et al. Specific skin manifestations in acute leukaemia with monocytic differentiation. Cancer 1993; 71: 124-32.
8. Ritter JH, Goldstein NS, Argenyi Z, Wick MR et al. Granulocytic sarcoma: an immunohistologic comparison with peripheral T-cell lymphoma in paraffin sections. J Cutan Pathol 1994; 21: 207-16.
9. Traweek ST, Arber DA, Rappaport H, Brynes RK et al. Extramedullary myeloid cell tumors. An immunohistochemical and morphologic study of 28 cases. Am J Surg Pathol 1993; 17: 1011-9.
10. Chan JKC, Sin VC, Wong KF, Ng CS et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplosm. Blood 1997; 89: 4501-13.
11. Ansai SI, Maeda K, Yamakawa M, Matsuda M et al. CD56-positive (nasal-type T/NK cell) lymphoma arising on the skin. Report of two cases and review of the literature. J Cutan Pathol 1997; 24: 468-76.
12. Jaffe ES, Chan JKC, Su U, Frizzera G et al. Report of the workshop on nasal and related extra-nodal angiocentric T/natural killer cell lymphomas. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathal 1996; 20: 103-11.
13. Kwong YL, Chan ACL, Liang R, Chiang AKS et al. CD56 + NK lymphomas: clinicopathological features and prognosis. Br J Haematol 1997; 97: 821-9.
14. Sun T, Brody J, Susin M, Marino J et al. Aggressive natural killer cell lymphoma/leukemia. A recently recognised clinicopathologic entity. Am J Surg Pathol 1993; 17: 1289-99.
15. Chaperot L, Bendriss N, Manches O, Gressin R et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood 2001; 97: 3210-7.
16. Feuillard J, Jacob MC, Valensi F, Maynadié M et al. Clinical and biologic features of CD4 +, CD56 + malignancies. Blood 2002; 5: 1556-63
17. Adachi M, Maeda K, Takekawa M, Hinoda Y et al. High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma. Am J Hematol 1994; 47: 278-82.
18. Brody JP, Allen S, Schulman P, Sun T et al. Acute agranular CD4-positive natural killer cell leukemia. Comprehensive clinico-pathologic studies including virologic and in vitro culture with inducing agents. Cancer 1995; 75: 2474-83.
19. Dummer R, Potoczna N, Häffner AC, Zimmerman DR et al. A primary cutaneous non-T, non-B CD4 +, CD56 + lymphoma. Arch Dermatol 1996; 132: 550-5.
20. DiGiuseppe JA, Louie DC, Williams JE, Miller DT et al. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study. Am J Surg Pathol 1997; 21: 1223-30.
21. Uchiyama N, Ito K, Kawai K, Sakamoto F et al. CD2 -, CD4 +, CD56 + agranular notural killer cell lymphoma of the skin. Am J Dermatopathol 1998; 20: 513-7.
22. Bagot M, Bouloc A, Charue D, Wechsler J et al. Do primary cutaneous non-T non-B CD4 +, CD56 + lymphomas belong to the myelo-monocytic lineage ? J Invest Dermatol 1998; 111: 1242-4.
23. Kameoka J, Ichinohasama R, Tanaka M, Miura I et al. A cutaneous agranular CD2 -, CD4 +, CD56 + lymphoma. Report of two cases and review of the literature. Am J clin Pathol 1998; 110: 478-88.
24. Ginarte M, Abalde MT, Peteira C, Fraga M et al. Blastoid NK cell leukemia/lymphoma with cutaneous lymphoma. Dermatology 2000; 201: 268-71.
25. Rakozy CK, Mohamed AN, Vo TD, Khatib G et al. CD56 + /CD4 + lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically and clinically diverse. Am J Clin Pathol 2001; 116: 168-76.
26. Kato N, Yasukawa K, Kimura K, Sugawara H et al. CD2 - CD4 + CD56 + hematodermic/ hematolymphoid malignancy. J Am Acad Dermatol 2001; 2: 231-8.
27. Kimura S, Kakazu N, Kuroda J, Akaogi T et al. Agranular CD4 +, CD56 + blastic natural killer leukemia/lymphoma. Ann Hematol 2001; 80: 228-31.
28. Bayerl MG, Rakozy CK, Mohamed AN, Vo TD et al. Blastic natural killer cell lymphoma/leukaemia. A report of seven cases. Am J clin Pathol 2002; 117: 41-50.
29. Knudsen H, Gronbaek K, Thor Straten P, Gisselo C et al. A case of lymphoblastoid natural killer (NK)-cell lymphoma: association with the NK-cell receptor complex CD94/NKG2 and TP53 intragenic deletion. Br J Dermatol 2002; 146: 148-53.
30. Savoia P, Fierro MT, Novelli M, Quaglino P et al. CD56-positive cutaneous lymphoma: a poorly recognised entity in the spectrum of primary cutaneous disease. Br J Dermatol 1997; 13: 966-71.
31. Wasik MA, Sackstein R, Novick D, Butmarc JR et al. Cutaneous CD56 + lorge T-cell lymphoma associated with high serum concentration of IL-2. Hum Pathol 1996; 27: 738-44.
32. Bastian BC, Ott G, Müller-Deubert S, Bröcker EB et al. Primary cutaneous natural killer/T-cell lymphoma. Arch Dermatol 1998; 134: 109-11.
33. Petrella T, Comeau MR, Maynadié M, Couillault G et al. "Agranular CD4 + CD56 + hematodermic neoplasm" (blastic NK-cell lymphoma) originates from a population of CD56 + precursor cells related to plasmacytoid monocytes. Am J Surg Pathol 2002; 26: 852-62.
34. Leroux D, Mugneret F, Callanan M, Radford-Weiss I et al. CD4 +, CD56 + DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique. Blood 2002; 99: 4154-9.